Scaling up existing drugs to address unmet medical needs and improve therapeutic outcomes may include modifying drug delivery, improving bioavailability, prolonging duration, expanding practice, or reducing side effects, including improving productivity, efficiency, safety, and patient compliance. Other strategies include redesigning drugs to target new indications, combining them with other therapies, or using advanced technologies such as nanomedicine. Enhancing existing drugs can help reduce costs and ensure patient outcomes have improved and the life of valuable treatments has been extended.
The Pharma R&D and Drug Discovery World Conference (PRDWC) provides an opportunity to explore innovations in developing existing drugs. The conference covers topics such as drug recycling, formulation improvements, combination therapies, and the use of cutting-edge technologies to improve the quality of current treatment Experts discuss how to make drugs a enhanced capacity of existing systems to address evolving healthcare challenges and improve patient care is discussed.